Effects of telmisartan and pyridoxamine on abdominal aorta vascular remodeling in spontaneously hypertensive rats
10.3760/cma.j.issn.0253-3758.2011.07.013
- VernacularTitle:吡哆胺和替米沙坦对大鼠腹主动脉平滑肌细胞增生、凋亡及血清糖基化终末产物的影响
- Author:
Feng JIANG
1
;
Peng-Li ZHU
;
Wei-Ping ZHENG
;
YUHui-zhen
;
Feng HUANG
;
Fan LIN
;
Hong LIN
;
Cheng-Ai SUN
Author Information
1. 福建省立医院
- Keywords:
Rats,inbred SHR;
Glycosylation end products,advanced;
Pyridoxamine;
Telmisartan
- From:
Chinese Journal of Cardiology
2011;39(7):658-663
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the effects of telmisartan and pyridoxamine on vascular smooth muscle cells (VSMCs) proliferation and apoptosis as well as abdominal aorta vascular remodeling in spontaneously hypertensive rats (SHRs). Methods SHRs randomly received placebo, telmisartan(6 mg*kg-1*d-1), pyridoxamine(200 mg*kg-1*d-1) or telmisartan (6 mg*kg-1*d-1) plus pyridoxamine (200 mg*kg-1*d-1, n=12 each) for 16 weeks. Wistar-Kyoto (WKY, n=12) rats serve as normotensive contro1. The systolic blood pressure (SBP) of rat was measured before and weekly thereafter. The serum advanced glycation end-products (AGEs) were detected by competitive ELISA. The serum super oxide dismutase (SOD) and nitric oxide (NO) were measured. The abdominal aorta were assessed by image analysis in HE stained sections. The VSMCs apoptosis and proliferation in abdominal aorta were detected with in situ end labeling technique and proliferating cell nuclear antigen (PCNA) immunohistoehemistry staining respectively. Results SBP were significantly lower in telmisartan and telmisartan plus pyridoxamine therapy group than in placebo treated hypertensive rats while not affected by pyridoxamine (P>0.05). Activity of SOD and NO were significantly higher and AGEs significantly lower in telmisartan, pyridoxamine and combination therapy treated SHRs than in placebo treated hypertensive rats(P<0.01). The elmisartan, pyridoxamine and combination therapy can significantly inhibit the PCNA expression and significantly enhance the apoptosis value in abdominal aorta(P<0.01). The efficacy of combined treatment was significantly higher than telmisartan and pyridoxamine alone(P<0.05). Conclusion Telmisartan and pyridoxamine could attenuate abdominal aorta vascular remodeling via reducing oxidative stress and AGEs production as well as restoring the balance of VSMCs proliferation and apoptosis in SHRs abdominal aorta.
